Professor of Neurology, Chair of the Leiden Centre for Translational Neuroscience at Leiden University Medical Centre (LUMC), Netherlands
Past President of the International Headache Society (IHS).
Professor Ferrari is the Principal Investigator of the EC-sponsored EUROHEAD program in which 9 European centres collaborate to decipher the molecular neurobiology of migraine. In 2009 he was the recipient of the NWO Spinoza Prize, the highest Dutch award in science.
CoLucid was founded in 2005 by Pappas Ventures to advance innovative drug candidates with the potential to provide safe and effective treatments for CNS disorders. The company's investors include Pappas Ventures, Domain Associates, Care Capital, Pearl Street Venture Funds and Triathlon Medical Ventures.
Lasmiditan is a member of a novel chemical class called "ditans." Lasmiditan penetrates the central nervous system (CNS) and selectively targets 5-HT1F receptors expressed in the trigeminal nerve pathway.